LXRXLEXICON PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of LEXICON PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LXRXEsta | $903M#2 | — | 5.2x#8 | 18.1x#4 | 60.2%#2 | 74.9%#3 | -98.2%#4 | -28.8%#7 | -26.4%#4 | — | 86.2%#1 | — |
| JANX | $993M#1 | — | 1.1x#1 | 99.3x#5 | -5.6%#5 | -64.7%#8 | -1576.7%#5 | -12.2%#4 | — | — | -30.6%#4 | — |
| AVTX | $889M#3 | — | 2.0x#4 | 15066.4x#6 | -86.6%#6 | -122.8%#9 | -123601.7%#6 | -17.4%#6 | -19.3%#3 | — | — | — |
| TBPH | $884M#4 | 16.4x#1 | 3.1x#5 | 8.2x#3 | 66.9%#1 | 287.7%#1 | -3.4%#1 | 36.6%#1 | — | — | 22.8%#3 | — |
| FTH | $879M#5 | — | 5.1x#7 | — | — | 30.1%#4 | — | -12.2%#3 | -15.2%#1 | — | — | — |
| IMMX | $853M#6 | — | 3.7x#6 | — | — | -36.0%#6 | — | -12.8%#5 | — | — | — | — |
| OLMA | $851M#7 | — | 2.0x#3 | — | — | -25.5%#5 | — | -37.7%#8 | — | — | — | — |
| ARDX | $847M#8 | — | 5.7x#9 | 2.1x#1 | 22.1%#3 | -59.0%#7 | -10.1%#2 | -41.6%#9 | -52.3%#5 | — | — | — |
| CYRX | $836M#9 | — | 1.7x#2 | 4.7x#2 | 12.4%#4 | 168.2%#2 | -20.9%#3 | 16.0%#2 | -16.5%#2 | 4#1 | 83.2%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice